Critical Reviews™ in Neurobiology
Выходит 3 номеров в год
ISSN Печать: 0892-0915
ISSN Онлайн: 2375-0014
SJR:
0.121
Том 16, 2004 Выпуск 1&2
DOI: 10.1615/CritRevNeurobiol.v16.i12
Neurosciences in the Third Millennium: A Tribute to Mimo Costa
v pages
DOI: 10.1615/CritRevNeurobiol.v16.i12.01
A GABAergic Cortical Deficit Dominates Schizophrenia Pathophysiology
pp. 1-23
DOI: 10.1615/CritRevNeurobiol.v16.i12.10
GABA, Reelin, and the Neurodevelopmental Hypothesis of Schizophrenia
pp. 25-32
DOI: 10.1615/CritRevNeurobiol.v16.i12.20
Neuroanatomical and Pharmacological Evidence for a Functional Interaction Between GABAergic and NPY-Y1 Transmission in the Amygdala of Y1R/LacZ Transgenic Mice
pp. 33-42
DOI: 10.1615/CritRevNeurobiol.v16.i12.30
The BDNF Gene: Exemplifying Complexity in Ca2+-Dependent Gene Expression
pp. 43-50
DOI: 10.1615/CritRevNeurobiol.v16.i12.40
Brain-Derived Neurotrophic Factor Activation of TrkB Protects Neurons from HIV-1/gp120-Induced Cell Death
pp. 51-58
DOI: 10.1615/CritRevNeurobiol.v16.i12.50
Cerebellar Granular Cell Cultures as an In Vitro Model for Antidepressant Drug-Induced Neurogenesis
pp. 59-65
DOI: 10.1615/CritRevNeurobiol.v16.i12.60
Neurosteroidogenesis: Relevance to Neurosteroid Actions in Brain and Modulation by Psychotropic Drugs
pp. 67-74
DOI: 10.1615/CritRevNeurobiol.v16.i12.70
Brain Neurosteroids in Gender-Related Aggression Induced by Social Isolation
pp. 75-82
DOI: 10.1615/CritRevNeurobiol.v16.i12.80
Neuroprotective and Neurotrophic Actions of the Mood Stabilizer Lithium: Can It Be Used to Treat Neurodegenerative Diseases?
pp. 83-90
DOI: 10.1615/CritRevNeurobiol.v16.i12.90
Protecting the Brain: The Search for a Clinically Effective Neuroprotective Drug for Stroke
pp. 91-98
DOI: 10.1615/CritRevNeurobiol.v16.i12.100
Adenosine A2A Receptor Antagonism and Neuroprotection: Mechanisms, Lights, and Shadows
pp. 99-106
DOI: 10.1615/CritRevNeurobiol.v16.i12.110
Transactivation of Cell Death Signals by Glutamate Transmission in Dopaminergic Neurons
pp. 107-119
DOI: 10.1615/CritRevNeurobiol.v16.i12.120
Dopamine Reuptake by Norepinephrine Neurons: Exception or Rule?
pp. 121-128
DOI: 10.1615/CritRevNeurobiol.v16.i12.130
AMPA Receptor Blockade Potentiates the Stimulatory Effect of L-DOPA on Dopamine Release in Dopamine-Deficient Corticostriatal Slice Preparation
pp. 129-139
DOI: 10.1615/CritRevNeurobiol.v16.i12.140
Peripheral Markers of Glutamatergic Dysfunction in Neurological Diseases: Focus on Ex Vivo Tools
pp. 141-146
DOI: 10.1615/CritRevNeurobiol.v16.i12.150
Cannabinoids and Reward: Interactions with the Opioid System
pp. 147-158
DOI: 10.1615/CritRevNeurobiol.v16.i12.160
Cannabinoid/Opioid Crosstalk in the Central Nervous System
pp. 159-172
DOI: 10.1615/CritRevNeurobiol.v16.i12.170
Spatio-Temporal Regulation of Neurotransmitter Release by PKC; Studies in Adrenal Chromaffin Cells
pp. 173-179
DOI: 10.1615/CritRevNeurobiol.v16.i12.180
5-Lipoxygenase as a Putative Link Between Cardiovascular and Psychiatric Disorders
pp. 181-186
DOI: 10.1615/CritRevNeurobiol.v16.i12.190